Neurosense Therapeutics is trading at $7.36 (+11.18%) mainly amid a broader biotech-sector rally.
- No new company-specific announcement clearly explains the September 22, 2026 advance; the latest identified item was a September 10 conference-presentation notice updated September 21.
- Price activity is elevated, but no volume data was provided.